Maobin Meng

1.0k total citations
46 papers, 778 citations indexed

About

Maobin Meng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Maobin Meng has authored 46 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Maobin Meng's work include Advanced Radiotherapy Techniques (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Maobin Meng is often cited by papers focused on Advanced Radiotherapy Techniques (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Maobin Meng collaborates with scholars based in China, United States and Sweden. Maobin Meng's co-authors include You Lü, Yao‐Li Cui, Zhiyong Yuan, Ruiming Zhang, Yong‐Song Guan, Zhiqiang Wu, Yan Chen, Lei Deng, Zeyun Mi and Xianming Mo and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Cell Death and Disease.

In The Last Decade

Maobin Meng

43 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maobin Meng China 19 239 232 231 162 151 46 778
Sang Soo Kim South Korea 18 283 1.2× 255 1.1× 288 1.2× 212 1.3× 124 0.8× 45 845
Howard Liu Australia 13 198 0.8× 202 0.9× 109 0.5× 78 0.5× 80 0.5× 43 555
Yongjie Shui China 15 154 0.6× 206 0.9× 207 0.9× 106 0.7× 75 0.5× 32 648
Shisuo Du China 18 241 1.0× 471 2.0× 412 1.8× 161 1.0× 212 1.4× 77 1.2k
Jennie Engstrand Sweden 14 246 1.0× 544 2.3× 92 0.4× 601 3.7× 109 0.7× 35 1.1k
Wan-Yee Lau Hong Kong 12 177 0.7× 444 1.9× 155 0.7× 459 2.8× 110 0.7× 15 1.2k
Jinming Yu China 16 364 1.5× 338 1.5× 163 0.7× 25 0.2× 106 0.7× 48 826
Tadamichi Hirano Japan 18 106 0.4× 195 0.8× 153 0.7× 476 2.9× 80 0.5× 61 917
Olivier Coatmeur France 4 194 0.8× 669 2.9× 146 0.6× 603 3.7× 152 1.0× 4 1.1k

Countries citing papers authored by Maobin Meng

Since Specialization
Citations

This map shows the geographic impact of Maobin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maobin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maobin Meng more than expected).

Fields of papers citing papers by Maobin Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maobin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maobin Meng. The network helps show where Maobin Meng may publish in the future.

Co-authorship network of co-authors of Maobin Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Maobin Meng. A scholar is included among the top collaborators of Maobin Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maobin Meng. Maobin Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yanchen, Jing Wang, Maobin Meng, et al.. (2024). MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB. Cancer Biology and Medicine. 21(11). 1–17.
2.
Yan, Haohao, Yuxin Cai, Dao Xin, et al.. (2024). Treatment strategies for limited-stage small cell carcinoma of the esophagus: evidence from a Chinese multicenter cohort study and the American SEER database. Journal of Thoracic Disease. 16(11). 7787–7796. 1 indexed citations
3.
Wang, Xiaofeng, Nicholas G. Zaorsky, Huanhuan Wang, et al.. (2024). Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data. Radiotherapy and Oncology. 200. 110529–110529.
4.
5.
Gao, Miaomiao, Xiaofeng Wang, Yang Dong, et al.. (2023). Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation. Radiotherapy and Oncology. 190. 110023–110023. 2 indexed citations
6.
Wang, Huanhuan, Xin Liu, Nicholas G. Zaorsky, et al.. (2023). Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses. Radiotherapy and Oncology. 187. 109817–109817. 4 indexed citations
7.
Chen, Yi, Xin Wang, Bing Sun, et al.. (2022). [Expert Consensus on the Treatment of Antiangiogenic Agents for Radiation Brain Necrosis].. SHILAP Revista de lepidopterología. 25(5). 291–294. 2 indexed citations
8.
9.
Lan, Jie, Rui Li, Limei Yin, et al.. (2018). Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 101(1). 74–87. 84 indexed citations
10.
11.
Zhou, Qiang, Bingwen Zou, Yong Xu, et al.. (2014). DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus. Tumor Biology. 36(3). 1539–1548. 9 indexed citations
12.
Lan, Jie, Lei Deng, Jianxin Xue, et al.. (2013). Ablative Hypofractionated Radiotherapy Normalizes Tumor Vasculature in Lewis Lung Carcinoma Mice Model. Radiation Research. 179(4). 458–464. 29 indexed citations
13.
Zhao, Min & Maobin Meng. (2012). Merkel cell carcinoma with lymph node metastasis in the absence of a primary site: Case report and literature review. Oncology Letters. 4(6). 1329–1334. 8 indexed citations
14.
15.
Wen, Qinglian, Maobin Meng, Bo Yang, et al.. (2009). Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice. Cancer Science. 100(8). 1510–1519. 47 indexed citations
16.
Zheng, Ming‐Hua, Maobin Meng, Dian-na Gu, et al.. (2009). Effectiveness and tolerability of NSAIDs in the prophylaxis of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis. Current Therapeutic Research. 70(4). 323–334. 6 indexed citations
17.
Guo, Jia, et al.. (2009). Treatment of functional constipation with the Yun‐chang capsule: A double‐blind, randomized, placebo‐controlled, dose‐escalation trial. Journal of Gastroenterology and Hepatology. 25(3). 487–493. 17 indexed citations
18.
Meng, Maobin, Yao‐Li Cui, Yong‐Song Guan, et al.. (2008). Traditional Chinese Medicine Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma. The Journal of Alternative and Complementary Medicine. 14(8). 1027–1042. 26 indexed citations
19.
Zheng, Ming‐Hua, Jianling Bai, Maobin Meng, & Yongping Chen. (2008). Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update. Current Therapeutic Research. 69(4). 288–304. 10 indexed citations
20.
Meng, Maobin, Yao‐Li Cui, You Lü, et al.. (2008). Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Radiotherapy and Oncology. 92(2). 184–194. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang Soo Kim Breakdown of academic impact, for papers by Howard Liu Breakdown of academic impact, for papers by Yongjie Shui Breakdown of academic impact, for papers by Shisuo Du Breakdown of academic impact, for papers by Jennie Engstrand Breakdown of academic impact, for papers by Wan-Yee Lau Breakdown of academic impact, for papers by Jinming Yu Breakdown of academic impact, for papers by Tadamichi Hirano Breakdown of academic impact, for papers by Olivier Coatmeur
Rankless by CCL
2026